L Marinova-Mutafchieva

1.1k total citations
17 papers, 975 citations indexed

About

L Marinova-Mutafchieva is a scholar working on Rheumatology, Oncology and Immunology and Allergy. According to data from OpenAlex, L Marinova-Mutafchieva has authored 17 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Oncology and 5 papers in Immunology and Allergy. Recurrent topics in L Marinova-Mutafchieva's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (4 papers) and Asthma and respiratory diseases (4 papers). L Marinova-Mutafchieva is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (4 papers) and Asthma and respiratory diseases (4 papers). L Marinova-Mutafchieva collaborates with scholars based in United Kingdom, Denmark and Ukraine. L Marinova-Mutafchieva's co-authors include Marc Feldmann, Richard Williams, Ravinder N. Maini, Mona Sadeghian, Andrew D. Medhurst, Lauren Broom, David T. Dexter, John B. Davis, Anne‐Marie Malfait and Claudia Mauri and has published in prestigious journals such as The Journal of Immunology, Free Radical Biology and Medicine and Annals of the New York Academy of Sciences.

In The Last Decade

L Marinova-Mutafchieva

16 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Marinova-Mutafchieva United Kingdom 14 294 252 220 186 184 17 975
Stefan Jung Germany 19 376 1.3× 219 0.9× 118 0.5× 372 2.0× 240 1.3× 32 1.3k
Xianzhen Hu United States 17 468 1.6× 194 0.8× 59 0.3× 131 0.7× 225 1.2× 29 959
Pierluigi Baron Italy 20 248 0.8× 405 1.6× 55 0.3× 390 2.1× 325 1.8× 39 1.4k
Ralf Gold Germany 13 773 2.6× 315 1.3× 160 0.7× 140 0.8× 408 2.2× 26 1.5k
Alessandra Porzia Italy 18 294 1.0× 318 1.3× 47 0.2× 90 0.5× 215 1.2× 26 1.0k
Osamu Mimura Japan 18 164 0.6× 587 2.3× 46 0.2× 208 1.1× 160 0.9× 75 1.3k
Dominique Talabot Switzerland 4 444 1.5× 729 2.9× 60 0.3× 397 2.1× 163 0.9× 5 1.5k
Kaisa E. Happonen Sweden 14 349 1.2× 339 1.3× 115 0.5× 79 0.4× 376 2.0× 20 1.1k
Stefan Gingele Germany 19 241 0.8× 352 1.4× 129 0.6× 126 0.7× 404 2.2× 59 1.3k
G Hermans Belgium 6 948 3.2× 399 1.6× 163 0.7× 45 0.2× 171 0.9× 9 1.6k

Countries citing papers authored by L Marinova-Mutafchieva

Since Specialization
Citations

This map shows the geographic impact of L Marinova-Mutafchieva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Marinova-Mutafchieva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Marinova-Mutafchieva more than expected).

Fields of papers citing papers by L Marinova-Mutafchieva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Marinova-Mutafchieva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Marinova-Mutafchieva. The network helps show where L Marinova-Mutafchieva may publish in the future.

Co-authorship network of co-authors of L Marinova-Mutafchieva

This figure shows the co-authorship network connecting the top 25 collaborators of L Marinova-Mutafchieva. A scholar is included among the top collaborators of L Marinova-Mutafchieva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Marinova-Mutafchieva. L Marinova-Mutafchieva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Broom, Lauren, L Marinova-Mutafchieva, Mona Sadeghian, et al.. (2010). Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease. Free Radical Biology and Medicine. 50(5). 633–640. 80 indexed citations
3.
Marinova-Mutafchieva, L, Mona Sadeghian, Lauren Broom, et al.. (2009). Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6‐hydroxydopamine model of Parkinson’s disease. Journal of Neurochemistry. 110(3). 966–975. 177 indexed citations
4.
Marinova-Mutafchieva, L, Cem Gabay, Nina S. Funa, & Richard Williams. (2006). Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-β expression in the joint. Clinical & Experimental Immunology. 146(2). 287–293. 29 indexed citations
5.
Staines, Norman A., et al.. (2004). Constraints on the Efficacy of Mucosal Tolerance in Treatment of Human and Animal Arthritic Diseases. Annals of the New York Academy of Sciences. 1029(1). 250–259. 9 indexed citations
6.
Williams, Richard, L Marinova-Mutafchieva, Marc Feldmann, & Ravinder N. Maini. (2000). Evaluation of TNF-α and IL-1 Blockade in Collagen-Induced Arthritis and Comparison with Combined Anti-TNF-α/Anti-CD4 Therapy. The Journal of Immunology. 165(12). 7240–7245. 100 indexed citations
7.
Marinova-Mutafchieva, L, Richard Williams, Claudia Mauri, et al.. (2000). A comparative study into the mechanisms of action of anti–tumor necrosis factor α, anti-CD4, and combined anti–tumor necrosis factor α/anti-CD4 treatment in early collagen-induced arthritis. Arthritis & Rheumatism. 43(3). 638–638. 15 indexed citations
8.
Malfait, Anne‐Marie, Amna Malik, L Marinova-Mutafchieva, et al.. (1999). The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action.. PubMed. 162(10). 6278–83. 84 indexed citations
9.
Malfait, Anne‐Marie, et al.. (1999). The β2-Adrenergic Agonist Salbutamol Is a Potent Suppressor of Established Collagen-Induced Arthritis: Mechanisms of Action. The Journal of Immunology. 162(10). 6278–6283. 81 indexed citations
10.
Quattrocchi, Emilia, Marita J. Walmsley, Kylie A. Browne, et al.. (1999). Paradoxical Effects of Adenovirus-Mediated Blockade of TNF Activity in Murine Collagen-Induced Arthritis. The Journal of Immunology. 163(2). 1000–1009. 64 indexed citations
11.
Williams, Richard, Claudia Mauri, Lesley Mason, et al.. (1998). Therapeutic actions of cyclosporine and anti-tumor necrosis factor ? in collagen-induced arthritis and the effect of combination therapy. Arthritis & Rheumatism. 41(10). 1806–1812. 32 indexed citations
12.
Sanz, María‐Jesús, L Marinova-Mutafchieva, Patricia Green, et al.. (1998). IL-4-Induced Eosinophil Accumulation in Rat Skin Is Dependent on Endogenous TNF-α and α4 Integrin/VCAM-1 Adhesion Pathways. The Journal of Immunology. 160(11). 5637–5645. 22 indexed citations
13.
Sanz, María‐Jesús, L Marinova-Mutafchieva, Patricia Green, et al.. (1998). IL-4-induced eosinophil accumulation in rat skin is dependent on endogenous TNF-alpha and alpha 4 integrin/VCAM-1 adhesion pathways.. PubMed. 160(11). 5637–45. 27 indexed citations
14.
Ross, Susan, Richard Williams, Lesley Mason, et al.. (1997). Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. The Journal of Immunology. 159(12). 6253–6259. 105 indexed citations
15.
Marinova-Mutafchieva, L, Richard Williams, Lesley Mason, et al.. (1997). Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clinical & Experimental Immunology. 107(3). 507–512. 112 indexed citations
16.
Marinova-Mutafchieva, L & G Chakalova. (1992). Local immunosuppression determined by class II HLA antigen expression in patients with preclinical cervical carcinoma.. PubMed. 13(6). 494–7.
17.
Marinova-Mutafchieva, L, et al.. (1990). Positive effect of cyclophosphamide on the expression of MHC class II antigens.. PubMed. 12(8). 545–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Jung Breakdown of academic impact, for papers by Xianzhen Hu Breakdown of academic impact, for papers by Pierluigi Baron Breakdown of academic impact, for papers by Ralf Gold Breakdown of academic impact, for papers by Alessandra Porzia Breakdown of academic impact, for papers by Osamu Mimura Breakdown of academic impact, for papers by Dominique Talabot Breakdown of academic impact, for papers by Kaisa E. Happonen Breakdown of academic impact, for papers by Stefan Gingele Breakdown of academic impact, for papers by G Hermans
Rankless by CCL
2026